- Home
- ITRG vs TLSA Comparison
ITRG vs TLSA Comparison
Compare ITRG & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- TLSA
- Stock Information
- Founded
- ITRG 1997
- TLSA 2013
- Country
- ITRG Canada
- TLSA United Kingdom
- Employees
- ITRG N/A
- TLSA N/A
- Industry
- ITRG Precious Metals
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- ITRG Basic Materials
- TLSA Health Care
- Exchange
- ITRG Nasdaq
- TLSA Nasdaq
- Market Cap
- ITRG 277.2M
- TLSA 187.0M
- IPO Year
- ITRG N/A
- TLSA 2000
- Fundamental
- Price
- ITRG $1.48
- TLSA $1.45
- Analyst Decision
- ITRG Strong Buy
- TLSA
- Analyst Count
- ITRG 1
- TLSA 0
- Target Price
- ITRG $2.75
- TLSA N/A
- AVG Volume (30 Days)
- ITRG 1.1M
- TLSA 246.7K
- Earning Date
- ITRG 08-13-2025
- TLSA 07-22-2025
- Dividend Yield
- ITRG N/A
- TLSA N/A
- EPS Growth
- ITRG N/A
- TLSA N/A
- EPS
- ITRG N/A
- TLSA N/A
- Revenue
- ITRG $87,375,000.00
- TLSA N/A
- Revenue This Year
- ITRG $746.16
- TLSA N/A
- Revenue Next Year
- ITRG N/A
- TLSA N/A
- P/E Ratio
- ITRG N/A
- TLSA N/A
- Revenue Growth
- ITRG N/A
- TLSA N/A
- 52 Week Low
- ITRG $0.79
- TLSA $0.63
- 52 Week High
- ITRG $1.95
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- ITRG 43.07
- TLSA 48.43
- Support Level
- ITRG $1.44
- TLSA $1.43
- Resistance Level
- ITRG $1.55
- TLSA $1.81
- Average True Range (ATR)
- ITRG 0.08
- TLSA 0.09
- MACD
- ITRG -0.01
- TLSA -0.02
- Stochastic Oscillator
- ITRG 19.70
- TLSA 18.53
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.